SURTAVI

Investigator: Neal Kleiman, MD

Study Coordinator: Patricia Brinegar

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01586910

Phone: 713.441.3506

Protocol Number: Pro00008022

Description

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.
More to Explore